Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4276
International Tower Hill Mines
THM
$338M
| $35.2K | ﹤0.01% |
+13,823
| New | +$33K |
2026 Q3
0 quarters
|
|
4277
Gogo Inc
GOGO
$465M
| $35.2K | ﹤0.01% |
16,371
-1,381
| -8% | -$4.29K |
2025 Q2
5 quarters
|
|
4278
Evotec
EVO
$590M
| $35K | ﹤0.01% |
+20,480
| New | +$40.6K |
2026 Q3
0 quarters
|
|
4279
Natural Health Trends
NHTC
$6.21M
| $34.7K | ﹤0.01% |
+33,697
| New | +$55.4K |
2026 Q3
0 quarters
|
|
4280
KinderCare Learning Companies
KLC
$250M
| $34.7K | ﹤0.01% |
+18,658
| New | +$69.5K |
2026 Q3
0 quarters
|
|
4281
RLX Technology
RLX
$1.91B
| $33.7K | ﹤0.01% |
+19,833
| New | +$37.3K |
2026 Q3
0 quarters
|
|
4282
CALL
HIVE Digital Technologies
HIVE
$457M
| $33.6K | ﹤0.01% |
11,400
-6,600
| -37% | -$19.9K |
2026 Q2
1 quarter
|
|
4283
XBiotech
XBIT
$59.8M
| $32.7K | ﹤0.01% |
14,941
-19,816
| -57% | -$44.7K |
2025 Q2
5 quarters
|
|
4284
NovaBridge Biosciences American Depositary Shares
NBP
$96M
| $32.1K | ﹤0.01% |
23,551
-2,917
| -11% | -$5.12K |
2025 Q3
4 quarters
|
|
4285
Playboy Inc
PLBY
$143M
| $31.6K | ﹤0.01% |
30,837
+4,818
| +19% | +$5.65K |
2024 Q4
7 quarters
|
|
4286
America's Car Mart
CRMT
$7.77M
| $31.2K | ﹤0.01% |
+30,568
| New | +$81.9K |
2026 Q3
0 quarters
|
|
4287
Tigo Energy
TYGO
$49.4M
| $30.3K | ﹤0.01% |
33,288
-211,339
| -86% | -$287K |
2026 Q1
2 quarters
|
|
4288
PUT
Opendoor
OPEN
$1.15B
| $29.9K | ﹤0.01% |
+12,600
| New | +$45.2K |
2026 Q3
0 quarters
|
|
4289
Pliant Therapeutics
PLRX
$45.8M
| $29.8K | ﹤0.01% |
27,606
-13,208
| -32% | -$14.6K |
2024 Q2
9 quarters
|
|
4290
PLAYSTUDIOS Inc
MYPS
$57.8M
| $28.9K | ﹤0.01% |
+6,080
| New | +$35.4K |
2026 Q3
0 quarters
|
|
|
4291
CALL
Opendoor
OPEN
$1.15B
| $27K | ﹤0.01% |
+11,400
| New | +$40.9K |
2026 Q3
0 quarters
|
|
4292
SIMPPLE Ltd
SPPL
$25.7M
| $26.5K | ﹤0.01% |
13,305
-4
| -0% | -$10 |
2026 Q2
1 quarter
|
|
4293
Niu Technologies
NIU
$139M
| $25.9K | ﹤0.01% |
+13,929
| New | +$30.4K |
2026 Q3
0 quarters
|
|
4294
Rani Therapeutics
RANI
$60.6M
| $25.6K | ﹤0.01% |
32,420
-9,482
| -23% | -$7.56K |
2025 Q4
3 quarters
|
|
4295
Microbot Medical
MBOT
$69.2M
| $25.4K | ﹤0.01% |
21,153
+867
| +4% | +$1.4K |
2025 Q3
4 quarters
|
|
4296
NervGen Pharma
NGEN
$175M
| $23.1K | ﹤0.01% |
+12,086
| New | +$23.2K |
2026 Q3
0 quarters
|
|
4297
HF Foods Group
HFFG
$80.5M
| $22.9K | ﹤0.01% |
13,942
-7,236
| -34% | -$12.1K |
2026 Q2
1 quarter
|
|
4298
Elicio Therapeutics
ELTX
$44.2M
| $22.7K | ﹤0.01% |
+12,457
| New | +$34.6K |
2026 Q3
0 quarters
|
|
4299
Annovis Bio
ANVS
$36.4M
| $21.3K | ﹤0.01% |
+16,769
| New | +$27.3K |
2026 Q3
0 quarters
|
|
4300
Palisade Bio
PALI
$205M
| $19.8K | ﹤0.01% |
14,636
-71,342
| -83% | -$139K |
2025 Q4
3 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.